Anti-fibrotic effects of cardiac progenitor cells in a 3D-model of human cardiac fibrosis

被引:0
|
作者
Gartner, T. Bracco [1 ]
Deddens, J. C. [2 ]
Mol, E. A. [3 ]
Ferrer, M. M. [3 ]
Van Laake, L. W. [2 ]
Bouten, C. V. C. [4 ]
Khademhosseini, A. [5 ]
Suyker, W. J. L. [1 ]
Sluijter, J. P. G. [3 ]
Hjortnaes, J. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Cardiothorac Surg, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands
[4] Eindhoven Univ Technol, Dept Soft Tissue Biomech & Tissue Engn, Eindhoven, Netherlands
[5] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P142
引用
收藏
页码:S37 / S37
页数:1
相关论文
共 50 条
  • [41] Cyclosporin A has anti-fibrotic effects in human lung fibroblasts and in bleomycin- induced lung fibrosis model mice
    Yamazaki, Risa
    Fujita, Tetsuo
    Yanagihara, Madoka
    Nakamura, Hiroyuki
    Fujino, Hiromichi
    Kasuya, Yoshitoshi
    Murayama, Toshihiko
    FASEB JOURNAL, 2016, 30
  • [42] Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model
    Cong, Tao
    Jin, Xue-Yuan
    Zhao, Lin
    Ma, Long
    Li, Rui-Sheng
    Zhao, Ping
    Guo, Chang-Jiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4651 - 4661
  • [43] Human cardiac progenitor cells
    Hosoda, Toru
    Bearzi, Claudia
    Rota, Marcello
    Amano, Saori
    Valentini, Susanna
    Delucchi, Francesca
    Tillmanns, Jochen
    Nascimbene, Angelo
    De Angelis, Antonella
    Siggins, Robert
    Zias, Elias
    Quaini, Federico
    Urbanek, Konrad
    Leri, Annarosa
    Kajstura, Jan
    Bolli, Roberto
    Anversa, Piero
    CIRCULATION, 2006, 114 (18) : 162 - 163
  • [44] Characterization of human conjunctival cells grown in a 3D-model
    Diebold, Yolanda
    Garcia-Posadas, Laura
    Soriano-Romani, Laura
    Arranz-Valsero, Isabel
    Lopez-Garcia, Antonio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [45] Development and characterization of a novel in vitro human liver fibrosis model for efficacy testing of anti-fibrotic drugs based on 3D Human Liver Microtissues
    Kostadinova, Radina
    Neelakandhan, Aparna
    Kijanska, Monika
    Zapiorkowska, Natalia
    Grepper, Sue
    Steiert, Sabrina
    Strassfeld, Tobias
    Guye, Patrick
    Messner, Simon
    HEPATOLOGY, 2017, 66 : 215A - 215A
  • [46] TRPC - NFAT signaling inhibition mediates the cardiac anti-fibrotic effect of polyphenols
    Saliba, Y.
    Hajal, J.
    Chacar, S.
    Maroun, R.
    Smayra, V.
    Fares, N.
    ACTA PHYSIOLOGICA, 2017, 221 : 40 - 40
  • [47] Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection
    Andrea Cutrullis, Romina
    Javier Poklepovich, Tomas
    Postan, Miriam
    Leon Freilij, Hector
    Beatriz Petray, Patricia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (08) : 1024 - 1031
  • [48] Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver
    van de Bovenkamp, M.
    Groothuis, G. M. M.
    Meijer, D. K. F.
    Olinga, P.
    TOXICOLOGY IN VITRO, 2008, 22 (03) : 771 - 778
  • [49] Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
    Lin, Zesi
    Zheng, Lu-Cong
    Zhang, Hong-Jie
    Tsang, Siu Wai
    Bian, Zhao-Xiang
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [50] Combining the Anti-Fibrotic Actions of Serelaxin With the Anti-Oxidant, N-Acetylcysteine, Abrogates Cardiac Fibrosis in an Isoprenaline-Induced Murine Model of Cardiomyopathy
    Wang, Chao
    Kemp-Harper, Barbara K.
    Samuel, Chrishan S.
    HYPERTENSION, 2019, 74